Unique keratinization process in psoriasis: Late differentiation markers are abolished because of the premature cell death

被引:89
作者
Iizuka, H [1 ]
Takahashi, H [1 ]
Honma, M [1 ]
Ishida-Yamamoto, A [1 ]
机构
[1] Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan
关键词
psoriasis; keratinization; API; protein kinase c;
D O I
10.1111/j.1346-8138.2004.tb00672.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
The keratinization process in psoriasis is a unique phenomenon. We have proposed an organized system for keratinization in psoriasis based on the recognition of early and late differentiation markers combined with premature cell death. The early differentiation markers, such as involucrin, small proline-rich proteins (SPRR), cystatin A and transglutaminase 1, are more conspicuously expressed in psoriasis, while the late differentiation markers, such as profilaggrin and loricrin, are abolished. Keratinization markers that are not observed in the normal epidermis are also detected; these include SKALP/elafin as well as K6 and K16. With a markedly diminished turnover time, the psoriatic epidermis idly synthesizes differentiation markers that are mostly under the control of the protein kinase GAPI transcriptional control system. Because of the premature cell death, however, the late differentiation markers are not expressed. During the improvement of the lesion and the therefore longer turnover time, the late differentiation markers rapidly catch up to reveal their expression. This explains the rapid appearance of keratohyalin granules (profilaggrin) in the healing lesion of psoriasis. Thus the keratinization process in psoriasis can be explained by the accelerated keratinization combined with premature cell death. The keratinization process in psoriasis is unique, because both accelerated kerb atinization and premature cell death co-exist, resulting in the disappearance of late differentiation markers such as profilaggrin and loricrin. It is interesting to note that the premature cell death is also tinder the control of protein kinase C signaling.
引用
收藏
页码:271 / 276
页数:6
相关论文
共 47 条
[1]
Corneodesmosin expression in psoriasis vulgaris differs from normal skin and other inflammatory skin disorders [J].
Allen, M ;
Ishida-Yamamoto, A ;
McGrath, J ;
Davison, S ;
Iizuka, H ;
Simon, M ;
Guerrin, M ;
Hayday, A ;
Vaughan, R ;
Serre, G ;
Trembath, R ;
Barker, J .
LABORATORY INVESTIGATION, 2001, 81 (07) :969-976
[2]
Bernerd Francoise, 1993, Gene Expression, V3, P187
[3]
Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype [J].
Cook, PW ;
Piepkorn, M ;
Clegg, CH ;
Plowman, GD ;
DeMay, JM ;
Brown, JR ;
Pittelkow, MR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2286-2294
[4]
Transient expression of epidermal filaggrin in cultured cells causes collapse of intermediate filament networks with alteration of cell shape and nuclear integrity [J].
Dale, BA ;
Presland, RB ;
Lewis, SP ;
Underwood, RA ;
Fleckman, P .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (02) :179-187
[5]
DENNING MF, 1995, CELL GROWTH DIFFER, V6, P149
[6]
THE PROXIMAL PROMOTER OF THE MOUSE LORICRIN GENE CONTAINS A FUNCTIONAL AP-1 ELEMENT AND DIRECTS KERATINOCYTE-SPECIFIC BUT NOT DIFFERENTIATION-SPECIFIC EXPRESSION [J].
DISEPIO, D ;
JONES, A ;
LONGLEY, MA ;
BUNDMAN, D ;
ROTHNAGEL, JA ;
ROOP, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10792-10799
[7]
PROTEIN-KINASE-C REGULATES KERATINOCYTE TRANSGLUTAMINASE (TG(K)) GENE-EXPRESSION IN CULTURED PRIMARY MOUSE EPIDERMAL-KERATINOCYTES INDUCED TO TERMINALLY DIFFERENTIATE BY CALCIUM [J].
DLUGOSZ, AA ;
YUSPA, SH .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (04) :409-414
[8]
DLUGOSZ AA, 1994, CANCER RES, V54, P6413
[9]
MEASUREMENT OF THE RATE OF EPIDERMAL TERMINAL DIFFERENTIATION - EXPRESSION OF INVOLUCRIN BY S-PHASE KERATINOCYTES IN CULTURE AND IN PSORIATIC PLAQUES [J].
DOVER, R ;
WATT, FM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 89 (04) :349-352
[10]
The epidermis: Genes on - Genes off [J].
Eckert, RL ;
Crish, JF ;
Banks, EB ;
Welter, JF .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (04) :501-509